Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
About this item
Full title
Author / Creator
ADAURA Investigators , Wu, Yi-Long , Tsuboi, Masahiro , He, Jie , John, Thomas , Grohe, Christian , Majem, Margarita , Goldman, Jonathan W , Laktionov, Konstantin , Kim, Sang-We , Kato, Terufumi , Vu, Huu-Vinh , Lu, Shun , Lee, Kye-Young , Akewanlop, Charuwan , Yu, Chong-Jen , de Marinis, Filippo , Bonanno, Laura , Domine, Manuel , Shepherd, Frances A , Zeng, Lingmin , Hodge, Rachel , Atasoy, Ajlan , Rukazenkov, Yuri and Herbst, Roy S
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The incidence of recurrence after curative resection among patients with stage IB, II, or IIIA non–small-cell lung cancer is high and is only slightly lower with adjuvant chemotherapy. A randomized trial of adjuvant osimertinib involving patients with
EGFR
mutation–positive NSCLC showed a substantial decrease in recurrence. Central nervous sy...
Alternative Titles
Full title
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
Authors, Artists and Contributors
Author / Creator
Wu, Yi-Long
Tsuboi, Masahiro
He, Jie
John, Thomas
Grohe, Christian
Majem, Margarita
Goldman, Jonathan W
Laktionov, Konstantin
Kim, Sang-We
Kato, Terufumi
Vu, Huu-Vinh
Lu, Shun
Lee, Kye-Young
Akewanlop, Charuwan
Yu, Chong-Jen
de Marinis, Filippo
Bonanno, Laura
Domine, Manuel
Shepherd, Frances A
Zeng, Lingmin
Hodge, Rachel
Atasoy, Ajlan
Rukazenkov, Yuri
Herbst, Roy S
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2455564612
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2455564612
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2027071
